ELEM Biotech
ELEM Biotech creates populations of virtual humans to predict clinical and device outcomes and support decision-making in drug and medical-device development. They run supercomputer-based patient modeling and simulation (Alya Red) combining high-performance computing, computational biomechanics and data analysis, deployed as a cloud SaaS for in-silico trials. The platform simulates cardiovascular and respiratory systems on virtual patients to evaluate therapies, optimize device performance, and generate evidence for clinicians and developers. Customers include pharmaceutical and MedTech companies and contract research organizations. ELEM is a spin-off of the Barcelona Supercomputing Center and is headquartered in Barcelona.
ELEM Biotech
ELEM Biotech creates populations of virtual humans to predict clinical and device outcomes and support decision-making in drug and medical-device development. They run supercomputer-based patient modeling and simulation (Alya Red) combining high-performance computing, computational biomechanics and data analysis, deployed as a cloud SaaS for in-silico trials. The platform simulates cardiovascular and respiratory systems on virtual patients to evaluate therapies, optimize device performance, and generate evidence for clinicians and developers. Customers include pharmaceutical and MedTech companies and contract research organizations. ELEM is a spin-off of the Barcelona Supercomputing Center and is headquartered in Barcelona.
TL;DR
What they do: Physics-based 'Virtual Humans' platform (Alya Red / V.HEART) for in silico clinical trials and device simulation
Headquarters: Barcelona, Spain
Founded: 2018
Customers: Pharmaceutical companies, MedTech companies, and CROs
Recent funding stage: Pre-Seed (Dec 19, 2022)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Reducing reliance on physical trials by simulating clinical/device outcomes for drug and medical-device development and regulatory/commercial evidence generation.
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Most recent recorded round
Investor Signal
“European Innovation Council”